This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Renascience Co., Ltd.. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: **Nagahisa Yamaoka: An Innovator in Pharmaceutical Research**
Introduction
Nagahisa Yamaoka, an accomplished inventor based in Osaka, Japan, has contributed significantly to the field of pharmaceutical innovations. With a total of three patents to his name, Yamaoka has dedicated his research to developing novel compounds with therapeutic applications, specifically targeting plasminogen activator inhibitor-1 (PAI-1) activity.
Latest Patents
Yamaoka's latest patents focus on the inhibitory activities of PAI-1, which are critical in the prevention and treatment of various diseases. His inventions include a compound characterized by plasminogen activator inhibitor-1 inhibitory activity, and methods for utilizing this compound within pharmaceutical compositions. These innovations reflect Yamaoka's commitment to advancing medical science and providing new avenues for disease management associated with PAI-1 activity.
Career Highlights
Nagahisa Yamaoka works at Renascience Co., Ltd., where he has been integral in the research and development of innovative therapeutic solutions. His significant contributions to product innovation have positioned him as a leading figure in his field, demonstrating a passion for leveraging his expertise to create meaningful healthcare advancements.
Collaborations
In his professional journey, Yamaoka has collaborated with notable colleagues such as Toshio Miyata and Kenji Murano. This teamwork fosters an environment of creativity and innovation, enabling them to push the boundaries of scientific research and develop breakthroughs in the pharmaceutical landscape.
Conclusion
Nagahisa Yamaoka continues to exemplify the spirit of innovation within the pharmaceutical sector through his groundbreaking inventions. His dedication to understanding and inhibiting PAI-1 activity promises to enhance the treatment options available for various medical conditions, ultimately impacting patient care and health outcomes positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile